Directly observed treatment for multidrug-resistant tuberculosis: An economic evaluation in the United States of America and South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 5, Issue 12, 2001, Pages 1137-1142

  Wilton, P ^a   Smith, R D ^a   Coast, J ^a   Millar, M ^a   Karcher, A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Antimicrobial resistance; Conventional therapy; Cost effectiveness analysis; Directly observed therapy; Multidrug resistant tuberculosis; Susceptible tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AFRICA; ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG COST; HEALTH CARE COST; HUMAN; INDUSTRIALIZATION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEM ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES;

ANTITUBERCULAR AGENTS; COST-BENEFIT ANALYSIS; DECISION TREES; DIRECTLY OBSERVED THERAPY; EVALUATION STUDIES; HUMANS; MONTE CARLO METHOD; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; UNITED STATES;

EID: 0035671273     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The antibacterial paradox: Essential drugs, effectiveness and cost
2. Antimicrobial resistance: The importance of developing long term policy
3. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy
4. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa
5. Directly observed therapy for treatment completion of pulmonary tuberculosis
6. Nation wide survey of drug resistant-tuberculosis in the United States
7. Eleven years of community-based directly observed therapy for tuberculosis
8. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis
9. A cost-effectiveness analysis of directly observed therapy vs. self-administered therapy for the treatment of tuberculosis
10. Comparison of cost-effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: Experience from rural South Africa
11. The influence of program acceptability on the effectiveness of public health policy: A study of directly observed therapy for tuberculosis
12. Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: Are any modifications required?
13. The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus seroprevalence
14. A continuing survey of drug-resistant tuberculosis, New York, City, April 1994
15. Primer on medical decision analysis. Part 5 - Working with Markov processes